Gastrointestinal Stromal Tumors: A Retrospective Study at a Tertiary Care Center in Saudi Arabia in the Last Decade

被引:0
作者
Refai, Fahd [1 ]
机构
[1] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Dept Pathol, Jeddah, Saudi Arabia
关键词
tumor characteristics; risk assessment; epidemiology; saudi arabia; gastrointestinal stromal tumors; MANAGEMENT; DIAGNOSIS; MULTICENTER; PATHOLOGY; FEATURES; KIT;
D O I
10.7759/cureus.64560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Gastrointestinal stromal tumors (GISTs) are a significant subset of mesenchymal tumors primarily found in the gastrointestinal tract, impacting diagnostic and therapeutic approaches. Understanding their epidemiology is crucial for improving patient care and advancing treatment strategies. Methodology: Our study at a Saudi tertiary hospital analyzed 50 patients with GIST, focusing on demographics, tumor locations, and risk assessments. We examined predictors of tumor size, including mitosis frequency, and assessed the impact of anatomical location and risk on clinical outcomes using RStudio software (Posit, Boston, MA). Results: Among 50 patients with GIST, 36 (72.0%) were male with a median age of 60.5 years, and most tumors (33, 66.0%) were in the stomach. Risk assessments categorized tumors as follows: 20 (40.0%) low risk, 12 (24.0%) high risk, 7 (14.0%) moderate risk, 7 (14.0%) very low risk, and 4 (8.0%) no risk. Most tumors were low-grade (41, 82.0%) and nonmetastatic (47, 94.0%), predominantly spindle cell type (37, 74.0%). Tumor size varied significantly across risk categories: high-risk tumors averaged 10.3 cm versus 0.5 cm for no risk and 3.5 cm for very low risk ( P < 0.001). Mitosis frequency differed significantly by risk category and tumor grade ( P < 0.001). Tumor grade varied notably with risk categories and morphologic types, especially high-grade tumors in high-risk groups (8, 66.7%) and epithelioid tumors (2, 100%). Multivariable analysis identified predictors of tumor size: anatomical location (extra-GI, intra-abdominal; beta = 7.08, P = 0.011) and risk assessment (low risk, beta = 6.91, P = 0.001; moderate risk, beta = 11.2, P < 0.001; high risk, beta = 8.93, P < 0.001). Liver metastasis did not differ significantly across gender, anatomical location, risk assessment, or tumor grade. Conclusions: In Saudi Arabia, GISTs predominantly affect males and are primarily located in the stomach. Our findings highlight significant variations in tumor size and grade based on risk assessments and anatomical location. Most GISTs were low-grade, nonmetastatic, and spindle cell type, emphasizing the need for enhanced research to improve diagnostics, tailor treatments, and optimize outcomes in the region.
引用
收藏
页数:16
相关论文
共 29 条
[1]   Gastrointestinal stromal tumors A clinicopathological study [J].
Alghamdi, Hanan M. ;
Amr, Samir S. ;
Shawarby, Mohamed A. ;
Sheikh, Salwa S. ;
Alsayyah, Ahmed A. ;
Alamri, Ali M. ;
Ismail, Mona H. ;
Almarhabi, Ahmed ;
Alrefaee, Munir A. ;
Ahmed, Muhammad I. .
SAUDI MEDICAL JOURNAL, 2019, 40 (02) :126-130
[2]  
[Anonymous], 2022, Gastrointestinal Stromal Cancer
[3]   A whole population study of gastrointestinal stromal tumors in the Czech Republic and Slovakia [J].
Brabec, P. ;
Sufliarsky, J. ;
Linke, Z. ;
Plank, L. ;
Mrhalova, M. ;
Pavlik, T. ;
Klimes, D. ;
Gregor, J. .
NEOPLASMA, 2009, 56 (05) :459-464
[4]   Clinicopathological Features and Outcome of Gastrointestinal Stromal Tumors in an Afro-Caribbean Population [J].
Brady-West, Doreen ;
Blake, Garfield .
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2012, 104 (1-2) :72-77
[5]   Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate [J].
Chirieac, Lucian R. ;
Trent, Jonathan C. ;
Steinert, Dejka M. ;
Choi, Haesun ;
Yang, Ying ;
Zhang, Jiexin ;
Patel, Shreyaskumar R. ;
Benjamin, Robert S. ;
Raymond, A. Kevin .
CANCER, 2006, 107 (09) :2237-2244
[6]  
Demetri GD, 2010, J NATL COMPR CANC NE, V8, pS1
[7]   Phase II Trial of Neoadjuvant/Adjuvant Imatinib Mesylate (IM) for Advanced Primary and Metastatic/Recurrent Operable Gastrointestinal Stromal Tumor (GIST): Early Results of RTOG 0132/ACRIN 6665 [J].
Eisenberg, Burton L. ;
Harris, Jonathan ;
Blanke, Charles D. ;
Demetri, George D. ;
Heinrich, Michael C. ;
Watson, James C. ;
Hoffman, John P. ;
Okuno, Scott ;
Kane, John M. ;
von Mehren, Margaret .
JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (01) :42-47
[8]   Diagnosis and management of gastrointestinal stromal tumors: An up-to-date literature review [J].
El-Menyar, Ayman ;
Mekkodathil, Ahammed ;
Al-Thani, Hassan .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (06) :889-900
[9]   Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patients [J].
Farag, Sheima ;
van Coevorden, Frits ;
Sneekes, Esther ;
Grunhagen, Dirk J. ;
Reyners, Anna K. L. ;
Boonstra, Pieter A. ;
van der Graaf, Winette T. ;
Gelderblom, Hans J. ;
Steeghs, Neeltje .
EUROPEAN JOURNAL OF CANCER, 2017, 86 :318-325
[10]   Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].
Fletcher, CDM ;
Berman, JJ ;
Corless, C ;
Gorstein, F ;
Lasota, J ;
Longley, BJ ;
Miettinen, M ;
O'Leary, TJ ;
Remotti, H ;
Rubin, BP ;
Shmookler, B ;
Sobin, LH ;
Weiss, SW .
HUMAN PATHOLOGY, 2002, 33 (05) :459-465